Metabolic changes in prostate cancer patients with Androgen-ablation therapy (AAT) - UROCOR

Study identifier:NIS-OES-DUM-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Metabolic changes in prostate cancer patients with Androgen-ablation therapy (AAT)

Medical condition

Prostatic cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Male

Actual Enrollment

197

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Mar 2011
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2012 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria